Huntington's disease is a devastating, fatal neurological illness with little means of treatment, but a new study in mice ...

Researchers designed tiny particles that can be implanted at a cancer tumor site, where they deliver two types of therapy: heat and chemotherapy.

The in vivo cell therapy seed Carisma Therapeutics planted with Moderna in 2022 is starting to sprout. | The in vivo cell ...

The human brain's glymphatic system, instrumental in removing toxins, has been visualized in living people through MRI ...

New Approach to Fight Huntington's Disease Shows Early Promise ... fatal neurological illness with little means of treatment, but a new study in mice offers a glimmer of hope.

Israeli researchers believe they've found a way of identifying and removing senescent cells by adapting a new generation of ...

Reid runs the lab where the study was done and is a senior author of the research. The similarity between the cancers lets researchers look at mice to figure ... system to fight the preleukemic ...

Brenus Pharma has announced the publication of a scientific article describing its new "off-the-shelf" cancer treatment in ...

Researchers have developed an innovative CAR T-cell therapy to combat glioblastoma, the most common malignant brain tumor in ...

Glioblastoma is the most common kind of malignant brain tumor in adults. So far, no treatment has been able to make this ...

The studies show that the state of aggression in male mice and the state of arousal in ... build upon previous research from the Anderson lab, in particular a study published in Cell last year ...